# the Efficacy and Safety of Ondansetron Oral Soluble Pellicles

> **NCT06282211** · PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital of Xinxiang Medical College** · enrollment: 184 (estimated)

## Conditions studied

- Nausea and Vomiting

## Interventions

- **DRUG:** Ondansetron Oral Soluble Pellicles

## Key facts

- **NCT ID:** NCT06282211
- **Lead sponsor:** The First Affiliated Hospital of Xinxiang Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-20
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-12-29
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282211, "the Efficacy and Safety of Ondansetron Oral Soluble Pellicles". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06282211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*